| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
RYTM
Rhythm Pharmaceuticals
|
Jun 15, 2026 | BUY |
Strong Buy
+25.2% avg upside
19 analysts
|
$133.00
37.38% Upside
|
+6.8% |
|
SPTX
Seaport Therapeutics, Inc.
|
Jun 09, 2026 | BUY |
Strong Buy
+95.4% avg upside
4 analysts
|
$30.00
65.10% Upside
|
· |
|
MPLT
MapLight Therapeutics, Inc.
|
Jun 02, 2026 | BUY |
Strong Buy
+33.1% avg upside
11 analysts
|
$36.00
24.90% Upside
|
-0.7% |
|
IMUX
Immunic
|
May 28, 2026 | BUY |
Strong Buy
+166.0% avg upside
21 analysts
|
$25.00
75.96% Upside
|
-7.4% |
|
SION
Sionna Therapeutics, Inc.
|
May 25, 2026 | BUY |
Strong Buy
+45.8% avg upside
11 analysts
|
$55.00
47.41% Upside
|
-13.0% |
|
BMRN
BioMarin Pharmaceutical
|
May 24, 2026 | HOLD |
Strong Buy
+72.8% avg upside
52 analysts
|
$68.00
24.34% Upside
|
+4.0% |
|
NGNE
Neurogene
|
May 13, 2026 | BUY |
Buy
+55.5% avg upside
23 analysts
|
$46.00
45.82% Upside
|
-15.0% |
|
LXEO
Lexeo Therapeutics, Inc.
|
May 12, 2026 | BUY |
Strong Buy
+313.8% avg upside
11 analysts
|
$17.00
244.79% Upside
|
-10.7% |
|
RAPP
Rapport Therapeutics, Inc.
|
May 12, 2026 | BUY |
Strong Buy
+45.9% avg upside
12 analysts
|
$56.00
49.99% Upside
|
-1.0% |
|
NMRA
Neumora Therapeutics, Inc.
|
May 12, 2026 | HOLD |
Buy
+422.4% avg upside
11 analysts
|
$3.00
98.75% Upside
|
-3.2% |
|
XENE
Xenon
|
May 08, 2026 | BUY |
Strong Buy
+19.0% avg upside
28 analysts
|
$86.00
62.49% Upside
|
-7.2% |
|
CTNM
Contineum Therapeutics, Inc. Class A
|
May 08, 2026 | BUY |
Strong Buy
+70.7% avg upside
8 analysts
|
$28.00
134.56% Upside
|
-11.8% |
|
ALKS
Alkermes
|
May 08, 2026 | BUY |
Strong Buy
-17.6% avg upside
34 analysts
|
$45.00
0.02% Upside
|
+29.6% |
|
ACAD
ACADIA Pharmaceuticals
|
May 07, 2026 | HOLD |
Strong Buy
+65.9% avg upside
42 analysts
|
$24.00
10.97% Upside
|
-4.3% |
|
NBIX
Neurocrine
|
May 06, 2026 | BUY |
Strong Buy
+7.8% avg upside
37 analysts
|
$188.00
18.79% Upside
|
+8.7% |
|
QURE
uniQure
|
May 05, 2026 | BUY |
Strong Buy
+16.1% avg upside
29 analysts
|
$28.00
39.50% Downside
|
+16.8% |
|
VRTX
Vertex Pharmaceuticals
|
May 05, 2026 | HOLD |
Strong Buy
-2.6% avg upside
61 analysts
|
$466.00
3.11% Upside
|
+8.2% |
|
IONS
Ionis Pharmaceuticals
|
Apr 30, 2026 | HOLD |
Strong Buy
+13.3% avg upside
43 analysts
|
$86.00
16.05% Upside
|
-2.0% |
|
DFTX
Definium Therapeutics
|
Apr 24, 2026 | BUY |
Strong Buy
+44.9% avg upside
20 analysts
|
$30.00
22.60% Upside
|
+8.7% |
|
BIIB
Biogen
|
Apr 04, 2026 | BUY |
Strong Buy
+25.1% avg upside
51 analysts
|
$214.00
8.91% Upside
|
+15.3% |
|
PEPG
PepGen Inc.
|
Apr 04, 2026 | BUY |
Strong Buy
+493.6% avg upside
8 analysts
|
$12.00
570.37% Upside
|
-14.8% |
|
ANRO
Alto Neuroscience, Inc.
|
Apr 02, 2026 | BUY |
Strong Buy
+33.3% avg upside
13 analysts
|
$33.00
45.05% Upside
|
-2.4% |
|
DNLI
Denali Therapeutics
|
Mar 29, 2026 | BUY |
Strong Buy
+60.2% avg upside
24 analysts
|
$41.00
75.91% Upside
|
+21.3% |
|
LBRX
LB Pharmaceuticals, Inc.
|
Mar 27, 2026 | BUY |
Strong Buy
+50.1% avg upside
7 analysts
|
$40.00
33.26% Upside
|
+17.0% |
|
CMPS
COMPASS Pathways
|
Mar 25, 2026 | BUY |
Strong Buy
+63.6% avg upside
18 analysts
|
$14.00
11.71% Upside
|
+112.5% |
|
GHRS
GH Research
|
Mar 06, 2026 | BUY |
Strong Buy
+64.5% avg upside
11 analysts
|
$32.00
43.80% Upside
|
+36.2% |
|
VTGN
VistaGen Therapeutics
|
Feb 13, 2026 | HOLD |
Hold
+287.9% avg upside
8 analysts
|
$1.00
49.20% Upside
|
+17.6% |
|
ALNY
Alnylam Pharma
|
Feb 12, 2026 | BUY |
Strong Buy
+23.6% avg upside
51 analysts
|
$444.00
59.67% Upside
|
-8.3% |
|
ALEC
Alector
|
Dec 22, 2025 | HOLD |
Hold
+532.1% avg upside
14 analysts
|
— | +49.0% |
|
ABOS
Acumen Pharmaceuticals
|
Dec 16, 2025 | BUY |
Strong Buy
+258.9% avg upside
10 analysts
|
$10.00
342.55% Upside
|
+11.9% |
|
DYN
Dyne Therapeutics
|
Dec 15, 2025 | BUY |
Strong Buy
+92.7% avg upside
29 analysts
|
$36.00
81.82% Upside
|
+1.1% |
|
LONA
LeonaBio
|
Sep 19, 2024 | HOLD |
Buy
+13.9% avg upside
9 analysts
|
— | -16.8% |
|
CLYM
Climb Bio
|
Jun 03, 2023 | BUY |
Strong Buy
+57.9% avg upside
18 analysts
|
$5.00
56.41% Downside
|
+182.7% |
|
WVE
Wave Life Sciences
|
May 12, 2022 | HOLD |
Strong Buy
+260.5% avg upside
28 analysts
|
$3.00
51.36% Downside
|
+207.8% |
|
IRON
Disc Medicine
|
Feb 28, 2022 | HOLD |
Strong Buy
+20.2% avg upside
21 analysts
|
$20.00
71.68% Downside
|
-38.7% |
|
OBSEF
ObsEva
|
Aug 16, 2017 | BUY |
Buy
+10799900.0% avg upside
8 analysts
|
$18.00
17999900.09% Upside
|
· |
|
NBRVF
Nabriva Therapeutics
|
Mar 10, 2017 | BUY |
Buy
+13374900.0% avg upside
9 analysts
|
$20.00
19999900.00% Upside
|
· |
|
ACIU
AC Immune SA
|
Nov 23, 2016 | BUY |
Strong Buy
+233.3% avg upside
5 analysts
|
— | -1.4% |
|
FATE
Fate Therapeutics
|
Jun 20, 2016 | BUY |
Buy
+475.7% avg upside
31 analysts
|
— | +49.0% |
|
TBPH
Theravance Biopharma
|
Jun 20, 2016 | BUY |
Buy
+12.2% avg upside
18 analysts
|
$29.00
74.92% Upside
|
+70.2% |
|
TPST
Tempest Therapeutics
|
May 06, 2016 | HOLD |
Buy
+1669.9% avg upside
18 analysts
|
$7.00
469.06% Upside
|
-76.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.